Laparoscopic magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: systematic review and pooled analysis

被引:38
|
作者
Guidozzi, Nadia [1 ]
Wiggins, Tom [1 ]
Ahmed, Ahmed R. [1 ]
Hanna, George B. [1 ]
Markar, Sheraz R. [1 ]
机构
[1] Imperial Coll London, Dept Surg & Canc, London, England
关键词
fundoplication; gastroesophageal reflux disease; magnetic sphincter augmentation; NISSEN FUNDOPLICATION; MANAGEMENT-SYSTEM; OUTCOMES; COMPLICATIONS; MULTICENTER; TRIAL;
D O I
10.1093/dote/doz031
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Magnetic sphincter augmentation (MSA) has been proposed as a less invasive, more appealing alternative intervention to fundoplication for the treatment of gastroesophageal reflux disease (GERD). The aim of this study was to evaluate clinical outcomes following MSA for GERD control in comparison with laparoscopic fundoplication. A systematic electronic search for articles was performed in Medline, Embase, Web of Science, and Cochrane Library for single-arm cohort studies or comparative studies (with fundoplication) evaluating the use of MSA. A random-effects meta-analysis for postoperative proton pump inhibitor (PPI) use, GERD-health-related quality of life (GERD-HRQOL), gas bloating, ability to belch, dysphagia, and reoperation was performed. The systematic review identified 6 comparative studies of MSA versus fundoplication and 13 single-cohort studies. Following MSA, only 13.2% required postoperative PPI therapy, 7.8% dilatation, 3.3% device removal or reoperation, and esophageal erosion was seen in 0.3%. There was no significant difference between the groups in requirement for postoperative PPI therapy (pooled odds ratio, POR = 1.08; 95%CI 0.40-2.95), GERD-HRQOL score (weighted mean difference, WMD= 0.34; 95%CI -0.70-1.37), dysphagia (POR = 0.94; 95%CI 0.57-1.55), and reoperation (POR = 1.23; 95%CI 0.26-5.8). However, when compared to fundoplicationMSA was associated with significantly less gas bloating (POR = 0.34; 95%CI 0.16-0.71) and a greater ability to belch (POR = 12.34; 95%CI 6.43-23.7). In conclusion, magnetic sphincter augmentation achieves good GERD symptomatic control similar to that of fundoplication, with the benefit of less gas bloating. The safety of MSA also appears acceptable with only 3.3% of patients requiring device removal. There is an urgent need for randomized data directly comparing fundoplication with MSA for the treatment of GERD to truly evaluate the efficacy of this treatment approach.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Early results of magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: Systematic review and meta-analysis
    Aiolfi, Alberto
    Asti, Emanuele
    Bernardi, Daniele
    Bonitta, Gianluca
    Rausa, Emanuele
    Siboni, Stefano
    Bonavina, Luigi
    INTERNATIONAL JOURNAL OF SURGERY, 2018, 52 : 82 - 88
  • [2] LINX® magnetic esophageal sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease: a systematic review and meta-analysis
    Skubleny, Daniel
    Switzer, Noah J.
    Dang, Jerry
    Gill, Richdeep S.
    Shi, Xinzhe
    de Gara, Christopher
    Birch, Daniel W.
    Wong, Clarence
    Hutter, Matthew M.
    Karmali, Shahzeer
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2017, 31 (08): : 3078 - 3084
  • [3] LINX® magnetic esophageal sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease: a systematic review and meta-analysis
    Daniel Skubleny
    Noah J. Switzer
    Jerry Dang
    Richdeep S. Gill
    Xinzhe Shi
    Christopher de Gara
    Daniel W. Birch
    Clarence Wong
    Matthew M. Hutter
    Shahzeer Karmali
    Surgical Endoscopy, 2017, 31 : 3078 - 3084
  • [4] Magnetic sphincter augmentation for gastroesophageal reflux disease: review of clinical studies
    Asti, Emanuele
    Aiolfi, Alberto
    Lazzari, Veronica
    Sironi, Andrea
    Porta, Matteo
    Bonavina, Luigi
    UPDATES IN SURGERY, 2018, 70 (03) : 323 - 330
  • [5] Magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: pros and cons
    Sterris, Jason A.
    Dunn, Colin P.
    Bildzukewicz, Nikolai A.
    Lipham, John C.
    CURRENT OPINION IN GASTROENTEROLOGY, 2020, 36 (04) : 323 - 328
  • [6] Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease
    Warren, Heather F.
    Reynolds, Jessica L.
    Lipham, John C.
    Zehetner, Joerg
    Bildzukewicz, Nikolai A.
    Taiganides, Paul A.
    Mickley, Jody
    Aye, Ralph W.
    Farivar, Alexander S.
    Louie, Brian E.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2016, 30 (08): : 3289 - 3296
  • [7] Magnetic sphincter augmentation in treating refractory gastroesophageal reflux disease: A systematic review and meta-analysis
    Zhuang, Qian Jun
    Tan, Nian Di
    Chen, Song Feng
    Zhang, Meng Yu
    Xiao, Ying Lian
    JOURNAL OF DIGESTIVE DISEASES, 2021, 22 (12) : 695 - 705
  • [8] Revaluation of the efficacy of magnetic sphincter augmentation for treating gastroesophageal reflux disease
    Zhang, Hongke
    Dong, Dinghui
    Liu, Zhengwen
    He, Shuixiang
    Hu, Liangshuo
    Lv, Yi
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2016, 30 (09): : 3684 - 3690
  • [9] Postoperative Dysphagia Following Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease
    Tsai, Catherine
    Steffen, Rudolf
    Kessler, Ulf
    Merki, Hans
    Lipham, John
    Zehetner, Joerg
    SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, 2020, 30 (04) : 322 - 326
  • [10] Magnetic sphincter augmentation for gastroesophageal reflux disease: review of clinical studies
    Emanuele Asti
    Alberto Aiolfi
    Veronica Lazzari
    Andrea Sironi
    Matteo Porta
    Luigi Bonavina
    Updates in Surgery, 2018, 70 : 323 - 330